Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Melatonin receptor type 1A gene linked to Alzheimer's disease in old age.

Sulkava S, Muggalla P, Sulkava R, Ollila HM, Peuralinna T, Myllykangas L, Kaivola K, Stone DJ, Traynor BJ, Renton AE, Rivera AM, Helisalmi S, Soininen H, Polvikoski T, Hiltunen M, Tienari PJ, Huttunen HJ, Paunio T.

Sleep. 2018 Jul 1;41(7). doi: 10.1093/sleep/zsy103.

2.

Hippocampal Sclerosis in the Oldest Old: A Finnish Population-Based Study.

Kero M, Raunio A, Polvikoski T, Tienari PJ, Paetau A, Myllykangas L.

J Alzheimers Dis. 2018;63(1):263-272. doi: 10.3233/JAD-171068.

3.

Mitochondrial oxodicarboxylate carrier deficiency is associated with mitochondrial DNA depletion and spinal muscular atrophy-like disease.

Boczonadi V, King MS, Smith AC, Olahova M, Bansagi B, Roos A, Eyassu F, Borchers C, Ramesh V, Lochmüller H, Polvikoski T, Whittaker RG, Pyle A, Griffin H, Taylor RW, Chinnery PF, Robinson AJ, Kunji ERS, Horvath R.

Genet Med. 2018 Mar 8. doi: 10.1038/gim.2017.251. [Epub ahead of print]

PMID:
29517768
4.

CAIDE Dementia Risk Score, Alzheimer and cerebrovascular pathology: a population-based autopsy study.

Hooshmand B, Polvikoski T, Kivipelto M, Tanskanen M, Myllykangas L, Mäkelä M, Oinas M, Paetau A, Solomon A.

J Intern Med. 2018 Jun;283(6):597-603. doi: 10.1111/joim.12736. Epub 2018 Mar 14.

PMID:
29411449
5.

Alzheimer risk loci and associated neuropathology in a population-based study (Vantaa 85+).

Mäkelä M, Kaivola K, Valori M, Paetau A, Polvikoski T, Singleton AB, Traynor BJ, Stone DJ, Peuralinna T, Tienari PJ, Tanskanen M, Myllykangas L.

Neurol Genet. 2018 Jan 18;4(1):e211. doi: 10.1212/NXG.0000000000000211. eCollection 2018 Feb.

6.

Heterozygous TYROBP deletion (PLOSLFIN) is not a strong risk factor for cognitive impairment.

Kaivola K, Jansson L, Saarentaus E, Kiviharju A, Rantalainen V, Eriksson JG, Strandberg TE, Polvikoski T, Myllykangas L, Tienari PJ.

Neurobiol Aging. 2018 Apr;64:159.e1-159.e4. doi: 10.1016/j.neurobiolaging.2017.12.008. Epub 2017 Dec 18.

PMID:
29336840
7.

MEGF10 related myopathies: A new case with adult onset disease with prominent respiratory failure and review of reported phenotypes.

Harris E, Marini-Bettolo C, Töpf A, Barresi R, Polvikoski T, Bailey G, Charlton R, Tellez J, MacArthur D, Guglieri M, Lochmüller H, Bushby K, Straub V.

Neuromuscul Disord. 2018 Jan;28(1):48-53. doi: 10.1016/j.nmd.2017.09.017. Epub 2017 Oct 12.

PMID:
29128256
8.

Hippocampal sclerosis, hippocampal neuron loss patterns and Tdp-43 in the aged population.

Hokkanen SRK, Hunter S, Polvikoski TM, Keage HAD, Minett T, Matthews FE, Brayne C; MRC CFAS and CC75C Study Group.

Brain Pathol. 2017 Aug 18. doi: 10.1111/bpa.12556. [Epub ahead of print]

PMID:
28833898
9.

Complex phenotypes associated with STIM1 mutations in both coiled coil and EF-hand domains.

Harris E, Burki U, Marini-Bettolo C, Neri M, Scotton C, Hudson J, Bertoli M, Evangelista T, Vroling B, Polvikoski T, Roberts M, Töpf A, Bushby K, McArthur D, Lochmüller H, Ferlini A, Straub V, Barresi R.

Neuromuscul Disord. 2017 Sep;27(9):861-872. doi: 10.1016/j.nmd.2017.05.002. Epub 2017 May 4.

PMID:
28624464
10.

Amygdala α-Synuclein Pathology in the Population-Based Vantaa 85+ Study.

Raunio A, Myllykangas L, Kero M, Polvikoski T, Paetau A, Oinas M.

J Alzheimers Dis. 2017;58(3):669-674. doi: 10.3233/JAD-170104.

PMID:
28482633
11.

Population-based analysis of pathological correlates of dementia in the oldest old.

Tanskanen M, Mäkelä M, Notkola IL, Myllykangas L, Rastas S, Oinas M, Lindsberg PJ, Polvikoski T, Tienari PJ, Paetau A.

Ann Clin Transl Neurol. 2017 Feb 12;4(3):154-165. doi: 10.1002/acn3.389. eCollection 2017 Mar.

12.

Novel HSPB1 mutation causes both motor neuronopathy and distal myopathy.

Lewis-Smith DJ, Duff J, Pyle A, Griffin H, Polvikoski T, Birchall D, Horvath R, Chinnery PF.

Neurol Genet. 2016 Oct 31;2(6):e110. eCollection 2016 Dec.

13.

Muscle hypertrophy as the presenting sign in a patient with a complete FHL1 deletion.

Willis TA, Wood CL, Hudson J, Polvikoski T, Barresi R, Lochmüller H, Bushby K, Straub V.

Clin Genet. 2016 Aug;90(2):166-70. doi: 10.1111/cge.12695. Epub 2016 Jan 8.

PMID:
27409453
14.

Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia.

Chen A, Akinyemi RO, Hase Y, Firbank MJ, Ndung'u MN, Foster V, Craggs LJ, Washida K, Okamoto Y, Thomas AJ, Polvikoski TM, Allan LM, Oakley AE, O'Brien JT, Horsburgh K, Ihara M, Kalaria RN.

Brain. 2016 Jan;139(Pt 1):242-58. doi: 10.1093/brain/awv328. Epub 2015 Dec 14.

15.

Capillary amyloid-β protein deposition in a population-based study (Vantaa 85+).

Mäkelä M, Paetau A, Polvikoski T, Myllykangas L, Tanskanen M.

J Alzheimers Dis. 2016;49(1):149-57. doi: 10.3233/JAD-150241.

PMID:
26444758
16.

Genome-wide association study of neocortical Lewy-related pathology.

Peuralinna T, Myllykangas L, Oinas M, Nalls MA, Keage HA, Isoviita VM, Valori M, Polvikoski T, Paetau A, Sulkava R, Ince PG, Zaccai J, Brayne C, Traynor BJ, Hardy J, Singleton AB, Tienari PJ.

Ann Clin Transl Neurol. 2015 Sep;2(9):920-31. doi: 10.1002/acn3.231. Epub 2015 Aug 18.

17.

Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles.

Hunter S, Minett T, Polvikoski T, Mukaetova-Ladinska E, Brayne C; Cambridge City over-75s Cohort Collaboration.

Alzheimers Res Ther. 2015 Aug 28;7(1):57. doi: 10.1186/s13195-015-0141-2.

18.

Mutational spectrum and phenotypic variability of VCP-related neurological disease in the UK.

Figueroa-Bonaparte S, Hudson J, Barresi R, Polvikoski T, Williams T, Töpf A, Harris E, Hilton-Jones D, Petty R, Willis TA, Longman C, Dougan CF, Parton MJ, Hanna MG, Quinlivan R, Farrugia ME, Guglieri M, Bushby K, Straub V, Lochmüller H, Evangelista T.

J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):680-1. doi: 10.1136/jnnp-2015-310362. Epub 2015 Jun 23. No abstract available.

19.

Phenotypic variability of TRPV4 related neuropathies.

Evangelista T, Bansagi B, Pyle A, Griffin H, Douroudis K, Polvikoski T, Antoniadi T, Bushby K, Straub V, Chinnery PF, Lochmüller H, Horvath R.

Neuromuscul Disord. 2015 Jun;25(6):516-21. doi: 10.1016/j.nmd.2015.03.007. Epub 2015 Mar 18.

20.

EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia.

Boczonadi V, Müller JS, Pyle A, Munkley J, Dor T, Quartararo J, Ferrero I, Karcagi V, Giunta M, Polvikoski T, Birchall D, Princzinger A, Cinnamon Y, Lützkendorf S, Piko H, Reza M, Florez L, Santibanez-Koref M, Griffin H, Schuelke M, Elpeleg O, Kalaydjieva L, Lochmüller H, Elliott DJ, Chinnery PF, Edvardson S, Horvath R.

Nat Commun. 2014 Jul 3;5:4287. doi: 10.1038/ncomms5287.

21.

Pyramidal neurons of the prefrontal cortex in post-stroke, vascular and other ageing-related dementias.

Foster V, Oakley AE, Slade JY, Hall R, Polvikoski TM, Burke M, Thomas AJ, Khundakar A, Allan LM, Kalaria RN.

Brain. 2014 Sep;137(Pt 9):2509-21. doi: 10.1093/brain/awu172. Epub 2014 Jun 28.

PMID:
24974383
22.

Two recurrent mutations are associated with GNE myopathy in the North of Britain.

Chaouch A, Brennan KM, Hudson J, Longman C, McConville J, Morrison PJ, Farrugia ME, Petty R, Stewart W, Norwood F, Horvath R, Chinnery PF, Costigan D, Winer J, Polvikoski T, Healy E, Sarkozy A, Evangelista T, Pogoryelova O, Eagle M, Bushby K, Straub V, Lochmüller H.

J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1359-65. doi: 10.1136/jnnp-2013-306314. Epub 2014 Apr 2.

PMID:
24695763
23.

Long-term incidence of depression and predictors of depressive symptoms in older stroke survivors.

Allan LM, Rowan EN, Thomas AJ, Polvikoski TM, O'Brien JT, Kalaria RN.

Br J Psychiatry. 2013 Dec;203(6):453-60. doi: 10.1192/bjp.bp.113.128355. Epub 2013 Oct 24.

PMID:
24158880
24.

Relationships between white matter hyperintensities, cerebral amyloid angiopathy and dementia in a population-based sample of the oldest old.

Tanskanen M, Kalaria RN, Notkola IL, Mäkelä M, Polvikoski T, Myllykangas L, Sulkava R, Kalimo H, Paetau A, Scheltens P, Barkhof F, van Straaten E, Erkinjuntti T.

Curr Alzheimer Res. 2013 Dec;10(10):1090-7.

PMID:
24156259
25.

Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study.

Hooshmand B, Polvikoski T, Kivipelto M, Tanskanen M, Myllykangas L, Erkinjuntti T, Mäkelä M, Oinas M, Paetau A, Scheltens P, van Straaten EC, Sulkava R, Solomon A.

Brain. 2013 Sep;136(Pt 9):2707-16. doi: 10.1093/brain/awt206.

26.

Early-onset cataracts, spastic paraparesis, and ataxia caused by a novel mitochondrial tRNAGlu (MT-TE) gene mutation causing severe complex I deficiency: a clinical, molecular, and neuropathologic study.

Lax NZ, Gnanapavan S, Dowson SJ, Alston CL, He L, Polvikoski TM, Jaros E, O'Donovan DG, Yarham JW, Turnbull DM, Dean AF, Taylor RW.

J Neuropathol Exp Neurol. 2013 Feb;72(2):164-75. doi: 10.1097/NEN.0b013e31828129c5.

PMID:
23334599
27.

Increased expression of fatty acid binding protein 4 and leptin in resident macrophages characterises atherosclerotic plaque rupture.

Lee K, Santibanez-Koref M, Polvikoski T, Birchall D, Mendelow AD, Keavney B.

Atherosclerosis. 2013 Jan;226(1):74-81. doi: 10.1016/j.atherosclerosis.2012.09.037. Epub 2012 Oct 5.

28.

Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population.

Kero M, Paetau A, Polvikoski T, Tanskanen M, Sulkava R, Jansson L, Myllykangas L, Tienari PJ.

Neurobiol Aging. 2013 May;34(5):1518.e1-3. doi: 10.1016/j.neurobiolaging.2012.09.017. Epub 2012 Oct 24.

PMID:
23102935
29.

Presymptomatic late-onset Pompe disease identified by the dried blood spot test.

Wagner M, Chaouch A, Müller JS, Polvikoski T, Willis TA, Sarkozy A, Eagle M, Bushby K, Straub V, Lochmüller H.

Neuromuscul Disord. 2013 Jan;23(1):89-92. doi: 10.1016/j.nmd.2012.09.004. Epub 2012 Oct 10.

PMID:
23062590
30.

Cauda equina syndrome secondary to intradural renal cell carcinoma metastasis haemorrhage.

Dobson GM, Polvikoski T, Nissen JJ, Holliman D.

Br J Neurosurg. 2013 Apr;27(2):249-50. doi: 10.3109/02688697.2012.724122. Epub 2012 Sep 17.

PMID:
22985045
31.

Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study.

Davis DH, Muniz Terrera G, Keage H, Rahkonen T, Oinas M, Matthews FE, Cunningham C, Polvikoski T, Sulkava R, MacLullich AM, Brayne C.

Brain. 2012 Sep;135(Pt 9):2809-16. doi: 10.1093/brain/aws190. Epub 2012 Aug 9.

32.

Mitochondrial DNA deletions and depletion within paraspinal muscles.

Campbell GR, Reeve A, Ziabreva I, Polvikoski TM, Taylor RW, Reynolds R, Turnbull DM, Mahad DJ.

Neuropathol Appl Neurobiol. 2013 Jun;39(4):377-89. doi: 10.1111/j.1365-2990.2012.01290.x.

33.

Hippocampal neuronal atrophy and cognitive function in delayed poststroke and aging-related dementias.

Gemmell E, Bosomworth H, Allan L, Hall R, Khundakar A, Oakley AE, Deramecourt V, Polvikoski TM, O'Brien JT, Kalaria RN.

Stroke. 2012 Mar;43(3):808-14. doi: 10.1161/STROKEAHA.111.636498. Epub 2011 Dec 29.

PMID:
22207507
34.

Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors.

Allan LM, Rowan EN, Firbank MJ, Thomas AJ, Parry SW, Polvikoski TM, O'Brien JT, Kalaria RN.

Brain. 2011 Dec;134(Pt 12):3716-27. doi: 10.1093/brain/awr273.

35.

Prevalence and severity of cerebral amyloid angiopathy: a population-based study on very elderly Finns (Vantaa 85+).

Tanskanen M, Mäkelä M, Myllykangas L, Notkola IL, Polvikoski T, Sulkava R, Kalimo H, Paetau A.

Neuropathol Appl Neurobiol. 2012 Jun;38(4):329-36. doi: 10.1111/j.1365-2990.2011.01219.x.

PMID:
21916927
36.

Ganglioneuroblastic transformation in olfactory neuroblastoma.

Bates T, Plessis DD, Polvikoski T, Sloan P, McQueen A, Meikle D, Kelly C, Robinson M.

Head Neck Pathol. 2012 Mar;6(1):150-5. doi: 10.1007/s12105-011-0293-8. Epub 2011 Sep 14.

37.

APOE and AβPP gene variation in cortical and cerebrovascular amyloid-β pathology and Alzheimer's disease: a population-based analysis.

Peuralinna T, Tanskanen M, Mäkelä M, Polvikoski T, Paetau A, Kalimo H, Sulkava R, Hardy J, Lai SL, Arepalli S, Hernandez D, Traynor BJ, Singleton A, Tienari PJ, Myllykangas L.

J Alzheimers Dis. 2011;26(2):377-85. doi: 10.3233/JAD-2011-102049.

38.

A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy.

Hicks D, Sarkozy A, Muelas N, Köehler K, Huebner A, Hudson G, Chinnery PF, Barresi R, Eagle M, Polvikoski T, Bailey G, Miller J, Radunovic A, Hughes PJ, Roberts R, Krause S, Walter MC, Laval SH, Straub V, Lochmüller H, Bushby K.

Brain. 2011 Jan;134(Pt 1):171-182. doi: 10.1093/brain/awq294.

39.

Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old.

Polvikoski TM, van Straaten EC, Barkhof F, Sulkava R, Aronen HJ, Niinistö L, Oinas M, Scheltens P, Erkinjuntti T, Kalaria RN.

Neurology. 2010 Dec 7;75(23):2071-8. doi: 10.1212/WNL.0b013e318200d6f9. Epub 2010 Nov 3.

40.

Education, the brain and dementia: neuroprotection or compensation?

EClipSE Collaborative Members, Brayne C, Ince PG, Keage HA, McKeith IG, Matthews FE, Polvikoski T, Sulkava R.

Brain. 2010 Aug;133(Pt 8):2210-6. doi: 10.1093/brain/awq185.

PMID:
20826429
41.

Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study.

Ahtiluoto S, Polvikoski T, Peltonen M, Solomon A, Tuomilehto J, Winblad B, Sulkava R, Kivipelto M.

Neurology. 2010 Sep 28;75(13):1195-202. doi: 10.1212/WNL.0b013e3181f4d7f8. Epub 2010 Aug 25.

PMID:
20739645
42.

Astrocytoma in a breast cancer lineage: part of the BRCA2 phenotype?

Wilson BT, Douglas SF, Polvikoski T.

J Clin Oncol. 2010 Oct 20;28(30):e596-8. doi: 10.1200/JCO.2010.28.9173. Epub 2010 Aug 16. No abstract available.

PMID:
20713847
43.

Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies.

Ihara M, Polvikoski TM, Hall R, Slade JY, Perry RH, Oakley AE, Englund E, O'Brien JT, Ince PG, Kalaria RN.

Acta Neuropathol. 2010 May;119(5):579-89. doi: 10.1007/s00401-009-0635-8. Epub 2010 Jan 21.

44.

alpha-Synuclein pathology in the spinal cord autonomic nuclei associates with alpha-synuclein pathology in the brain: a population-based Vantaa 85+ study.

Oinas M, Paetau A, Myllykangas L, Notkola IL, Kalimo H, Polvikoski T.

Acta Neuropathol. 2010 Jun;119(6):715-22. doi: 10.1007/s00401-009-0629-6.

PMID:
20037761
45.

Brain neurons express ornithine decarboxylase-activating antizyme inhibitor 2 with accumulation in Alzheimer's disease.

Mäkitie LT, Kanerva K, Polvikoski T, Paetau A, Andersson LC.

Brain Pathol. 2010 May;20(3):571-80. doi: 10.1111/j.1750-3639.2009.00334.x. Epub 2009 Sep 22.

PMID:
19832840
46.

Neuropathologic findings of dementia with lewy bodies (DLB) in a population-based Vantaa 85+ study.

Oinas M, Polvikoski T, Sulkava R, Myllykangas L, Juva K, Notkola IL, Rastas S, Niinistö L, Kalimo H, Paetau A.

J Alzheimers Dis. 2009;18(3):677-89. doi: 10.3233/JAD-2009-1169.

PMID:
19625740
47.

Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL.

Yamamoto Y, Ihara M, Tham C, Low RW, Slade JY, Moss T, Oakley AE, Polvikoski T, Kalaria RN.

Stroke. 2009 Jun;40(6):2004-11. doi: 10.1161/STROKEAHA.108.528299. Epub 2009 Apr 9.

48.

Neurofibrillary tau pathology modulated by genetic variation of alpha-synuclein.

Peuralinna T, Oinas M, Polvikoski T, Paetau A, Sulkava R, Niinistö L, Kalimo H, Hernandez D, Hardy J, Singleton A, Tienari PJ, Myllykangas L.

Ann Neurol. 2008 Sep;64(3):348-52. doi: 10.1002/ana.21446.

PMID:
18661559
49.

Apolipoprotein E (APOE) and lipoprotein lipase (LPL) gene variants and carotid atherosclerotic lesions in the oldest old: a population-based autopsy study.

Myllykangas L, Lammie GA, Notkola IL, Sulkava R, Polvikoski T.

Arch Gerontol Geriatr. 2009 Jul-Aug;49(1):108-12. doi: 10.1016/j.archger.2008.05.007. Epub 2008 Jul 10.

PMID:
18619685
50.

Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study.

Tanskanen M, Peuralinna T, Polvikoski T, Notkola IL, Sulkava R, Hardy J, Singleton A, Kiuru-Enari S, Paetau A, Tienari PJ, Myllykangas L.

Ann Med. 2008;40(3):232-9. doi: 10.1080/07853890701842988.

PMID:
18382889

Supplemental Content

Loading ...
Support Center